Dissolvable Microneedles – From Product Development to Commercial Manufacturing

3/22/2022 09:55 - 10:25

For the past decade, innovation in microneedles has been a focus within the pharmaceutical world. Today, microneedles are seen as a viable option for the delivery of drugs such as biologicals, vaccines and difficult-to-deliver small molecules through the skin, in both immediate-release and long-acting products. The widely recognized benefits of transdermal administration in terms of pain-free delivery, convenience and patient compliance, make microneedles an ideal platform for an increasing number of therapeutic areas.

In the first half of the presentation, you will get an insight into the options of transdermal applications. A brief comparison of a variety of transdermal application including injection systems will provide a better understanding of problems faced while using such system. In the second half of the presentation, we will take a deep look into the field of microneedle systems. In addition to current designs and compositions we will look into the development, manufacturing and analytical testing of microneedle system. The final topic will be the commercial manufacturing of microneedle systems. What are the challenges for CDMOs and how to develop suitable manufacturing equipment in a still shifting microneedle technology environment?

This will give you the complete picture from product development to commercial manufacturing.

Dr. Sebastian Braun, Head of Formulation Development 1 and Head of Manufacturing MAP, LTS Lohmann Therapie-Systeme AG